CVS Health Corporation (0HRS.L)
USD 45.95
(2.5%)
USD 45.95
(2.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 13.42 Billion | 16.17 Billion | 18.26 Billion | 15.86 Billion | 12.84 Billion | 8.86 Billion |
| Net Income | 8.36 Billion | 4.16 Billion | 7.89 Billion | 7.19 Billion | 6.63 Billion | -596 Million |
| Depreciation & Amortization | 4.36 Billion | 4.24 Billion | 4.51 Billion | 4.44 Billion | 4.37 Billion | 2.71 Billion |
| Deferred income taxes | -676 Million | -2.07 Billion | -428 Million | -570 Million | -654 Million | 87 Million |
| Stock-based compensation | 588 Million | 447 Million | 484 Million | 400 Million | 453 Million | 280 Million |
| Change in working capital | 15 Million | 7 Billion | 3.94 Billion | 3.15 Billion | 1.49 Billion | -112 Million |
| Other non-cash items | 765 Million | 2.39 Billion | 1.85 Billion | 1.24 Billion | 548 Million | 6.48 Billion |
| Investing Cash Flow | -20.88 Billion | -5.04 Billion | -5.26 Billion | -5.53 Billion | -3.33 Billion | -43.28 Billion |
| Investments in PPE | -3.03 Billion | -2.72 Billion | -2.52 Billion | -2.43 Billion | -2.45 Billion | -2.03 Billion |
| Acquisitions | -16.61 Billion | -1.38 Billion | -146 Million | -26 Million | -444 Million | -41.39 Billion |
| Investment purchases | -9.04 Billion | -7.74 Billion | -9.96 Billion | -9.63 Billion | -7.53 Billion | -692 Million |
| Sales/Maturities of investments | 7.72 Billion | 6.72 Billion | 7.24 Billion | 6.46 Billion | 7.04 Billion | 817 Million |
| Other Investing Activities | 68 Million | 85 Million | 122 Million | 101 Million | 47 Million | 21 Million |
| Financing Cash Flow | 2.68 Billion | -10.51 Billion | -11.35 Billion | -7.69 Billion | -7.85 Billion | 36.81 Billion |
| Debt repayment | -7.93 Billion | -4.21 Billion | -10.25 Billion | -5.67 Billion | -9.05 Billion | -6.07 Billion |
| Dividends payments | -3.13 Billion | -2.9 Billion | -2.62 Billion | -2.62 Billion | -2.6 Billion | -2.03 Billion |
| Common Stock Repurchased | -2.01 Billion | -3.5 Billion | -168 Million | -88 Million | -112 Million | -97 Million |
| Common Stock Issuance | 277 Million | 551 Million | 549 Million | 264 Million | 210 Million | 242 Million |
| Other Financing Activities | -382 Million | -449 Million | 1.14 Billion | 689 Million | 3.71 Billion | 44.93 Billion |
| Accounts receivables | -6.26 Billion | -2.97 Billion | -2.7 Billion | -1.51 Billion | -2.15 Billion | -1.13 Billion |
| Accounts payables | 3.61 Billion | 4.26 Billion | 2.89 Billion | 2.76 Billion | 3.55 Billion | 2.48 Billion |
| Inventory | 1.23 Billion | -1.43 Billion | 735 Million | -973 Million | -1.07 Billion | -1.15 Billion |
| Other working capital | 1.42 Billion | 7.14 Billion | 3.01 Billion | 2.87 Billion | 1.18 Billion | -309 Million |
| Cash at beginning of period | 13.3 Billion | 12.69 Billion | 11.04 Billion | 5.95 Billion | 4.29 Billion | 1.9 Billion |
| Cash at end of period | 8.52 Billion | 13.3 Billion | 12.69 Billion | 8.13 Billion | 5.95 Billion | 4.29 Billion |
| Capital Expenditure | -3.03 Billion | -2.72 Billion | -2.52 Billion | -2.43 Billion | -2.45 Billion | -2.03 Billion |
| Effect of forex changes on cash | - | - | - | - | - | -4 Million |
| Net cash flow / Change in cash | -4.78 Billion | 614 Million | 1.64 Billion | 2.17 Billion | 1.65 Billion | 2.39 Billion |
| Free Cash Flow | 10.39 Billion | 13.45 Billion | 15.74 Billion | 13.42 Billion | 10.39 Billion | 6.82 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.77 Billion | 1.12 Billion | 8.36 Billion | 2.04 Billion | 2.26 Billion | 1.91 Billion |
| Depreciation & Amortization | 1.15 Billion | 1.13 Billion | 4.36 Billion | 1.13 Billion | 1.12 Billion | 1.1 Billion |
| Deferred income taxes | -124 Million | -217 Million | -676 Million | -316 Million | -447 Million | -68 Million |
| Stock-based compensation | 133 Million | 137 Million | 588 Million | 127 Million | 154 Million | 204 Million |
| Change in working capital | 161 Million | 2.72 Billion | 15 Million | -6.04 Billion | -732 Million | 2.75 Billion |
| Other non-cash items | 437 Million | -1.61 Billion | 765 Million | 416 Million | 349 Million | 469 Million |
| Investing Cash Flow | -1.62 Billion | -2.09 Billion | -20.88 Billion | -1.24 Billion | -771 Million | -10.36 Billion |
| Investments in PPE | -638 Million | -705 Million | -3.03 Billion | -911 Million | -545 Million | -591 Million |
| Acquisitions | -48 Million | -25 Million | -16.61 Billion | -120 Million | -18 Million | -9.38 Billion |
| Investment purchases | -3.23 Billion | -3.54 Billion | -9.04 Billion | -2.41 Billion | -2.12 Billion | -2.14 Billion |
| Sales/Maturities of investments | 2.26 Billion | 2.15 Billion | 7.72 Billion | 2.18 Billion | 1.9 Billion | 1.74 Billion |
| Other Investing Activities | 32 Million | 28 Million | 68 Million | 25 Million | 11 Million | 1 Million |
| Financing Cash Flow | 1.24 Billion | -1.22 Billion | 2.68 Billion | -972 Million | -2.69 Billion | 3.62 Billion |
| Debt repayment | -2.22 Billion | -2.5 Billion | -7.93 Billion | -232 Million | -1.94 Billion | -4.52 Billion |
| Dividends payments | -858 Million | -840 Million | -3.13 Billion | -779 Million | -779 Million | -795 Million |
| Common Stock Repurchased | 3 Million | -3.02 Billion | -2.01 Billion | 1 Million | 3 Million | 2 Million |
| Common Stock Issuance | 25 Million | 203 Million | 277 Million | 35 Million | 122 Million | 24 Million |
| Other Financing Activities | -142 Million | -64 Million | -382 Million | 3 Million | -96 Million | -127 Million |
| Accounts receivables | -210 Million | 3 Billion | -6.26 Billion | -2.34 Billion | -3.11 Billion | -53 Million |
| Accounts payables | 1.92 Billion | -1.41 Billion | 3.61 Billion | 1.15 Billion | 2.58 Billion | 1.08 Billion |
| Inventory | 277 Million | 1.66 Billion | 1.23 Billion | -72 Million | -495 Million | 972 Million |
| Other working capital | -1.83 Billion | -537 Million | 1.42 Billion | -4.78 Billion | 295 Million | 750 Million |
| Cash at beginning of period | 9.85 Billion | 8.52 Billion | 13.3 Billion | 13.37 Billion | 14.12 Billion | 14.95 Billion |
| Cash at end of period | 12.56 Billion | 10.1 Billion | 8.52 Billion | 8.52 Billion | 13.37 Billion | 14.12 Billion |
| Capital Expenditure | -638 Million | -705 Million | -3.03 Billion | -911 Million | -545 Million | -591 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 2.7 Billion | 1.58 Billion | -4.78 Billion | -4.85 Billion | -752 Million | -828 Million |
| Free Cash Flow | 2.45 Billion | 4.19 Billion | 10.39 Billion | -3.54 Billion | 2.17 Billion | 5.31 Billion |
STYRENIX
EICHERMOT
120110
8473
3302
226320